TCPWM
TMO icon

Traverso Chambers Private Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Traverso Chambers Private Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-360
Closed -$207K – 119
2023
Q1 		$207K Buy
+360
New +$203K 0.06% 112

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Traverso Chambers Private Wealth Management's TMO Position: Q2 2023 in Review

Traverso Chambers Private Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 360 shares — an estimated $207K sold.

Traverso Chambers Private Wealth Management first reported a position in TMO in Q1 2023 and held it in 1 quarter. The position peaked at $207K in Q1 2023. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Traverso Chambers Private Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Traverso Chambers Private Wealth Management sold 360 Thermo Fisher Scientific shares in Q2 2023, an estimated $207K.
  • Traverso Chambers Private Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 1 quarter.
  • Traverso Chambers Private Wealth Management's Thermo Fisher Scientific position peaked at $207K in Q1 2023.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Traverso Chambers Private Wealth Management's 13F filing for Q2 2023, filed 14 Jul 2023.